We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+12.47%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.13B
AUM Growth
+$203M
Cap. Flow
-$12.1M
Cap. Flow %
-0.57%
Top 10 Hldgs %
30.3%
Holding
2,428
New
30
Increased
109
Reduced
927
Closed
85

Sector Composition

Rank Sector Weight
1 Technology 24.26%
2 Financials 10.88%
3 Healthcare 10.85%
4 Consumer Discretionary 9.35%
5 Industrials 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRBR icon
501
BellRing Brands
BRBR
$1.28B
$415K 0.02%
7,482
-399
-5% -$19.2K
QLYS icon
502
Qualys
QLYS
$6.78B
$413K 0.02%
2,106
-36
-2% -$6.3K
FIX icon
503
Comfort Systems
FIX
$60.8B
$413K 0.02%
2,008
-66
-3% -$12.2K
PAYC icon
504
Paycom
PAYC
$10.1B
$413K 0.02%
1,996
-42
-2% -$8.88K
AOS icon
505
A.O. Smith
AOS
$8.49B
$412K 0.02%
4,998
-156
-3% -$11.5K
CZR icon
506
Caesars Entertainment
CZR
$6.04B
$412K 0.02%
8,779
-128
-1% -$5.68K
CHRW icon
507
C.H. Robinson
CHRW
$17.5B
$410K 0.02%
4,747
-70
-1% -$5.87K
APG icon
508
APi Group
APG
$18.8B
$409K 0.02%
17,736
-323
-2% -$6.23K
MTCH icon
509
Match Group
MTCH
$8.56B
$404K 0.02%
11,063
-441
-4% -$14.9K
SPSC icon
510
SPS Commerce
SPSC
$2.86B
$404K 0.02%
2,083
-68
-3% -$11.9K
IMGN
511
DELISTED
Immunogen Inc
IMGN
$403K 0.02%
13,608
-371
-3% -$7.39K
GLPI icon
512
Gaming and Leisure Properties
GLPI
$12.7B
$403K 0.02%
8,175
+109
+1% +$5.04K
ELS icon
513
Equity Lifestyle Properties
ELS
$12.6B
$403K 0.02%
5,707
-14
-0.2% -$953
HSIC icon
514
Henry Schein
HSIC
$10B
$402K 0.02%
5,314
-88
-2% -$6.16K
WFRD icon
515
Weatherford International
WFRD
$6.6B
$401K 0.02%
4,097
BBWI icon
516
Bath & Body Works
BBWI
$3.76B
$399K 0.02%
9,255
-216
-2% -$7.29K
FN icon
517
Fabrinet
FN
$20.3B
$396K 0.02%
2,081
-38
-2% -$6.51K
CHRD icon
518
Chord Energy
CHRD
$7.35B
$396K 0.02%
2,380
-75
-3% -$12.3K
ETSY icon
519
Etsy
ETSY
$7.4B
$395K 0.02%
4,873
-215
-4% -$15.4K
CYBR
520
DELISTED
CyberArk
CYBR
$394K 0.02%
1,800
ITCI
521
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$386K 0.02%
5,393
JNPR
522
DELISTED
Juniper Networks
JNPR
$383K 0.02%
12,979
-316
-2% -$8.68K
PECO icon
523
Phillips Edison & Co
PECO
$5.2B
$382K 0.02%
10,473
+56
+0.5% +$1.96K
NWSA icon
524
News Corp Class A
NWSA
$15.6B
$380K 0.02%
15,491
-270
-2% -$5.86K
RHI icon
525
Robert Half
RHI
$4.48B
$379K 0.02%
4,310
-120
-3% -$9.54K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2023 Portfolio in Review

As of Q4 2023, Metropolitan Life Insurance Company (MetLife) held 2,428 positions worth $2.13B, up 11% from $1.93B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 4.7%. Metropolitan Life Insurance Company (MetLife) opened 30 new positions and exited 85, leaving the 2,428-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2023 buy was iShares Broad USD Investment Grade Corporate Bond ETF: 578,568 shares worth $29.7M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares Core US Aggregate Bond ETF in Q4 2023, an estimated $38.1M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2023 reduction was Apple, cutting an estimated $2.39M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Vanguard Total Bond Market in Q4 2023, selling an estimated $72.5M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 30% of its $2.13B portfolio in Q4 2023.
  • Metropolitan Life Insurance Company (MetLife) opened 30 new positions and closed 85 in Q4 2023.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 11% quarter-over-quarter to $2.13B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.